Pilot study with Low-dose nivolumab in Advanced Neoplasms that are TMB-high
Sponsor: UZ Brussel
Phase: 2
Disease: Advanced solid tumors
EU trial number: 2026-525445-73-00
Population: Adults with histologically confirmed TMB-high advanced solid tumors who have failed standard curative and life-prolonging therapies, have ECOG performance status 0–1, are immune checkpoint inhibitor-naive, and lack access to reimbursed immunotherapy in Belgium.
Register Investigator Interest
Interested in offering this trial to suitable patients?